๐
Litak
cladribine
Leukemia, Hairy Cell
โ
Authorised
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Litak is indicated for the treatment of hairy-cell leukaemia.
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/litak